Related Experiment Video
Updated: Nov 25, 2025

Cryosectioning and Immunostaining Mouse Inner Ear Tissue: From Embryonic to Adult Stages
Published on: April 11, 2025
Effects of primary arterial hypertension on cochlear function
1Department of Audiology, Eskişehir Osmangazi University, Faculty of Health Sciences, Eskişehir, Turkey.
Insights
Hypertension (HT) is linked to poorer high-frequency hearing and reduced otoacoustic emission amplitudes. Early screening of auditory function is recommended for individuals with HT to detect potential hearing loss.
Area of Science:
- Otolaryngology
- Cardiology
- Audiology
Background:
- Hypertension (HT) is a prevalent chronic condition.
- Existing research on the link between HT and hearing impairment shows conflicting results.
- A clear consensus on HT's impact on auditory function is lacking.
Purpose of the Study:
- To evaluate and compare cochlear function in individuals with and without primary hypertension.
- To investigate potential differences in hearing thresholds and otoacoustic emission responses between hypertensive and normotensive groups.
Main Methods:
- The study included 34 patients with primary HT and 17 healthy controls.
- Cochlear function was assessed using conventional and ultra-high frequency audiometry (0.125-16 kHz).
- Transient evoked otoacoustic emissions (TEOAE) and distortion product otoacoustic emissions (DPOAE) were measured.
Main Results:
- Hypertensive patients showed significantly poorer hearing thresholds at ultra-high frequencies (8-16 kHz) compared to controls.
- No significant differences were observed in conventional hearing thresholds (0.125-8 kHz).
- TEOAE and DPOAE amplitudes were significantly lower in the hypertensive group.
Conclusions:
- Adults with HT exhibit diminished high-frequency hearing and reduced otoacoustic emission amplitudes.
- Auditory impairment associated with HT originates in the cochlea's ultra-high frequency regions.
- HT is a potential risk factor for hearing loss, necessitating auditory function screening in hypertensive individuals.
Background:
Hypertension (HT) is one of the most common chronic diseases. The existing literature on HT and hearing contains conflicting results, and no consensus has been reached yet.
Objectives:
This study aimed to investigate cochlear function in hypertensive and normotensive groups.
Methods:
This study was conducted on 34 patients with primary HT and 17 healthy adults. The Cochlear function was assessed with conventional audiometry (0.125-8 kHz), ultra-high frequency audiometry (10-16 kHz), the transient evoked otoacoustic emission (TEOAE) test, and the distortion product otoacoustic emission (DPOAE) test.
Results:
Hearing thresholds at 8, 10, 12.5, 14, and 16 kHz were significantly poorer in the HT group than in the control group (p < .05). There was no significant difference in the mean conventional thresholds between the groups. Compared to the control group, the patient group exhibited statistically significant lower amplitudes of TEOAE and DPOAE.
Conclusion:
This study demonstrated significantly poorer high-frequency hearing and lower otoacoustic emission amplitudes for adults with HT. Impairment in hearing thresholds associated with HT begins at ultra-high frequencies in the cochlea. HT may be a potential risk factor for the development of hearing loss; therefore, individuals with HT should be screened for auditory function.
More Related Videos
Related Concept Videos
Hypertension II: Pathophysiology
Hypertension and Regulation of Blood Pressure
The Cochlea
Hypertension I: Introduction
Auditory Pathway
When viewed cross-sectionally, the cochlea reveals the scala vestibuli and scala tympani flanking...
Hypertension III: Clinical Manifestations and Diagnostic Studies

